Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity
ObjectiveDetailed proteomic analysis in a cohort of patients with differing severity of COVID-19 disease identified biomarkers within the complement and coagulation cascades as biomarkers for disease severity has been reported; however, it is unclear if these proteins differ sufficiently from other...
Main Authors: | Abu Saleh Md Moin, Ahmed Al-Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.658304/full |
Similar Items
-
Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01) -
Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01) -
Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
by: Abu Saleh Md Moin, et al.
Published: (2021-06-01) -
Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2021-02-01) -
Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01)